Startup | May 09, 2022
InxMed raises US $ 15 million in Series B+ financing
The plan is to advance innovative therapies to drug-resistant cancers
The plan is to advance innovative therapies to drug-resistant cancers
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
The new building is expected to be commissioned by 2024. Post the expansion, Nanavati-Max Hospital will be amongst the largest private sector hospital in western India
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Lupin recognized the need to digitize more applications, improve scalability, decrease risk of security breaches and eliminate critical data loss
Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Upon closing, the Quakertown business will become an independent company called Microsize
The production suspension impacts commercial and clinical trial supply
This newly designed small-format detector is made up of caesium iodide technology and is extremely high in resolution, capable of capturing the fine detail of smaller anatomical structures present in paediatric patients
Subscribe To Our Newsletter & Stay Updated
